JKN2501

· Joincare Pharmaceutical Group Industry Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JKN2501, covering 2025-10-03 to 2025-10-03. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers [Phase 1]